Daniel G. Welch

Board Member at Seattle Genetics, Inc.

Are you Daniel G. Welch? Claim your profile
 
  • IDENTIFY corporate executives in Daniel G. Welch's network and community.
  • FOLLOW changes in Daniel G. Welch's employment and money-in-motion.
  • CONNECT with Daniel G. Welch through your network of contacts.

Daniel G. Welch's Executive Work History


Current
Past
To view Daniel G. Welch's complete executive work history,
Age
59
 
 

Daniel G. Welch's Biography


Daniel Welch has served as a member of our board of directors since November 2015. Mr. Welch has been an Executive Partner at Sofinnova Ventures since 2015. From 2003 until October 2014, Mr. Welch was the Chairman, Chief Executive Officer and President of InterMune, Inc., which was listed on the Nasdaq Stock Market until the acquisition of the company by Roche. During his tenure, InterMune secured registration of Esbriet, the first medicine approved for idiopathic pulmonary fibrosis in Europe and the United States. Mr. Welch built the InterMune development and commercial teams that delivered the successful approval and launches of Esbriet in ...

(Read More)

Source: Intercept Pharmaceuticals, Inc. on 04/05/2017

 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Daniel G. Welch. More specifically, you'll be able to:

  • IDENTIFY corporate executives in Daniel G. Welch's network and community.
  • FOLLOW changes in Daniel G. Welch's employment and money-in-motion.
  • CONNECT with Daniel G. Welch through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: Daniel G. Welch

Daniel G. Welch's Connections (155)


Chief Operating Officer, Seattle Genetics, Inc.
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.
Chairman of the Board, Sangamo
President, Chief Executive Officer and Chairman of the Board, Seattle Genetics, Inc.
Dir., President and Chief Executive Officer, Syros Pharmaceuticals, Inc.
Dir., President and Chief Executive Officer, Ultragenyx Pharmaceutical Inc.